Sign up for Newsletter
Be the first to know about clinical trials
near you
By entering your email, you agree to our
Terms and Condition & Privacy Policy
The CRO for Biotech, Powered by Technology
Vial is a contract research organization delivering faster and more efficient trials for sponsors through its end-to-end technology platform.
End-to-End Technology
The Vial Technology Platform leverages connected systems and intuitive design to run global trials efficiently at scale
Site Startup
Driven by process automatization, Vial’s Site Startup app enables lightning-fast onboarding. Sites can be activated in as few as 30 days.
Patient Recruiting
Vial's Patient Recruitment Platform recruits patients across 15+ channels and converts them to randomizations — radically reducing enrollment periods.
Electronic Source
Vial's eClinical Suite delivers high-quality data 
through connected data capture and review. Vial replaces paper source in trials — driving a significant change in trial workflows.
Vial CRO’s Therapeutic Experience
Our ClinOps expertise spans several therapeutic areas
Oncology
CRO
Dermatology
CRO
Ophthalmology
CRO
Gastroenterology
CRO
Neurology
CRO
Cardiology
CRO
Fast Startup and Consolidated Site Activation
Vial CRO's Site Startup app
enables sites to seamlessly onboard to our trials
The results: Lightning-fast onboarding. Sites can be activated in as few as 30 days.
Vial CRO's Technology Platform
Vial leverages connected systems and intuitive design to run global trials efficiently at scale
eSource
Finally, paper is out, and digital is in.
EDC
Speed and efficiency that sponsors love.
ePRO
Customizable for patients in your clinical study.
No-Nonsense Pricing
Vial offers sponsors fixed-pricing
agreements with no change orders — ever.
Flat-rate pricing
Zero change orders
Risk-share
on commitments
Accountability
on commitments
A fixed-fee pricing model guarantees a set budget for the entirety of a project, regardless of the time and expense that accrues. Vial reserves the right to modify pricing in accordance with amendments to the study design or protocol.
Vial offers fixed upfront pricing to benefit sponsors:
- Align Incentives
- Transparent budget visibility
- No unexpected charges/fees
- Shared accountability on commitments
- Build trust and deepen the relationship
- Experienced team committed to timelines
- Next-generation technology to streamline workflows and process
- A renowned scientific advisory board providing expert insight
- Deep industry relationships and a preferred site network provide an insider view on trial pain points, allowing us to target and prepare to prevent common errors or delays
What Our Sponsors Are Saying
Events
Past Events
Press Releases
Vial: Faster, Better, Cheaper CRO Powered by Technology, Announces Series B led by General Catalyst
Whitepaper
Tech-Enabled Remote Monitoring Part 1
Download the Vial CRO's white paper to learn more about each stakeholder’s benefits of tech-enabled trials.
Whitepaper
How Vial Revolutionized Patient Recruiting Using Multi-Channel Strategy and Powerful Technology
Download the Vial CRO's latest white paper to learn how Vial revolutionized patient recruiting using multi-channel strategy and powerful technology
Whitepaper
Looking Ahead: Oncology Clinical Trial Landscape in 2023
Download the Vial CRO's latest white paper on the oncology clinical trial landscape in 2023.
Experience Makes All The Difference
Vial offers a wealth
of experience running clinical trials across therapeutic areas.
Vial CRO is supported by a team of renowned Scientific Advisors who review and provide input on the strategy and direction of the contract research organization in order to build the infrastructure to advance medical research.
Dr. Guru Sonpavde
Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School
Dr. Neeraj Agarwal
Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah
Dr. Arvind Chaudhry
Director of Summit Cancer Centers, Medical Oncologist
Dr. Arati Rao
Head of Clinical Development at PACT Pharma
Dr. Luke Nordquist
CEO at Urology Cancer Center and XCancer Research
Dr. Antoni Ribas
Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA)
Dr. Arshad Khanani
More than 10 years as a Vitreo-Retinal Physician and Surgeon, as well as Director of Clinical Research at his practice, Sierra Eye Associates
Dr. Mark Lebwohl
Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City
Dr. David Pariser
Senior physician of Pariser Dermatology Specialist and Principal Investigator
Dr. Joseph Merola
Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School
Dr. Jonathan Zung
Chief Development Officer at Evelo Biosciences
Dr. Nancy Holekamp
Director of Retina Services at the Pepose Vision Institute
Talk to Sales
Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.
